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Objective: To investigate the associations between maternal pregestational body mass index (BMI),
gestational weight gain (GWG), and adverse pregnancy outcomes among Taiwanese women.
Materials and Methods: A retrospective cohort study was conducted among all singletons without fetal
anomalies delivered to women at Taipei Chang Gung Memorial Hospital between 2009 and 2015. Two
study cohorts were selected for analysis: all deliveries after 24 0/7 weeks of gestation (Cohort 1,
n¼ 12,064) and all live births after 37 0/7 weeks of gestation excluding maternal overt diabetes mellitus
and chronic hypertension (Cohort 2, n¼ 10,973). The associations between pregestational BMI, GWG
outside the 2009 Institute of Medicine (IOM) guidelines, and adverse pregnancy outcomes were assessed
using multivariable logistic regression analysis.
Results: In Cohort 1, the prevalence of pregestational underweight, normal weight, overweight, and
obesity was 14.0%, 74.8%, 9.0%, and 2.2%, respectively. Compared with the women with normal weight,
maternal underweight was associated with increased risk for placental abruption, small-for-gestational
age, and low birth weight (<2500 g). In contrast, overweight and obese women were at risk for gesta-
tional diabetes mellitus, preeclampsia, dysfunctional labor, cephalopelvic disproportion, large-for-
gestational age, and macrosomia (>4000 g). In Cohort 2, GWG below the IOM guidelines were associ-
ated with higher rates of gestational diabetes mellitus, small-for-gestational age, and low birth weight,
while GWG above the IOM guidelines were with higher rates of primary cesarean delivery, large-for-
gestational age, and macrosomia in women with pregestational underweight or normal weight.
Normal weight womenwere more likely to have placental abruption with GWG below the guidelines and
to have preeclampsia with GWG above the guidelines. For overweight and obese women, GWG below the
guidelines was associated with a higher rate of gestational diabetes mellitus, but GWG above the
guidelines was associated with a higher rate of macrosomia.
Conclusions: Women with abnormal pregestational BMI are at risk for adverse maternal and neonatal
outcomes. Moreover, GWG has a differential effect on the rates of adverse pregnancy outcomes between
women of different pregestational BMI categories.
Copyright © 2016, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
The continuum of overweight and obesity is a worldwide
epidemic; 33% of pregnant women are overweight or obese in the
UK [1], 12e38% of pregnant women are overweight and 11e40% arend Gynecology, Taipei Chang
aipei 105, Taiwan.
bstetrics & Gynecology. Published bobese in the US [2e4], and 10e24% of pregnant women are over-
weight or obese in China [5,6]. At the other end of the spectrum,
maternal underweight is also common; 4.3% of pregnant women in
the UK [1] and 11e13% of women in China [5,6] are underweight at
the ﬁrst antenatal visit.
Accumulating evidence shows that women with overweight or
obesity before pregnancy are at increased risk for adverse maternal
and neonatal outcomes compared with normal weight women [7].
These include gestational diabetes mellitus (GDM), gestational
hypertensive diseases, preterm birth, large-for-gestational agey Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
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addition to the increased risk of antenatal complications, there is an
increased risk of cesarean delivery and associated morbidities in
pregestational overweight or obesewomen [5,6,10e12]. In contrast,
maternal underweight was noted to be associated with suboptimal
fetal growth such as small-for-gestational age (SGA) and low birth
weight [5,6,10,12,14,15], although the association betweenmaternal
underweight and preterm birth is inconsistent [6,10,11,14]. Never-
theless, data on the prevalence of pregestational underweight,
overweight, and obesity and whether these women are at risks for
similar adverse pregnancy outcomes in Taiwanese women remain
scarce [11,16,17]. Furthermore, our recent study shows that women
with gestational weight gain (GWG) above or below the 2009
Institute of Medicine (IOM) guidelines are at risk for adverse
pregnancy outcomes [18]. It is, however, unclear whether similar
associations exist across all women or there is a differential effect of
GWG on the rate of adverse pregnancy outcome among women of
different pregestational weight categories.
Therefore, the objectives of this study were: (1) to investigate
the prevalence of pregestational underweight, normal weight,
overweight, and obesity deﬁned by body mass index (BMI) ac-
cording to the WHO classiﬁcation; (2) to study the associations
between maternal pregestational BMI and adverse maternal and
neonatal outcomes; and (3) to evaluate the effect of GWG on the
rates of adverse pregnancy outcomes between women of different
pregestational BMI categories in a Taiwanese population.
Materials and methods
A retrospective cohort study was conducted among all
singleton births to women who delivered at Taipei Chang Gung
Memorial Hospital between January 1, 2009 and December 31,
2015. The study data were obtained from a computerized obstet-
rics database that included demographic characteristics, medical
and obstetric histories, and information regarding the course of
the index pregnancy and perinatal outcomes. Details of the data-
base have been described previously [18,19]. The study was
approved by the Institutional Review Board of Chang Gung Me-
morial Hospital.
In this hospital, the height of each pregnant woman was
measured and her self-reported prepregnancy weight was recor-
ded at the ﬁrst antenatal visit. Height and the self-reported pre-
pregnancy weight were used to calculate the pregestational BMI
[calculated as weight (kg)/height (m)2], which was further cate-
gorized into four groups: underweight (<18.5 kg/m2), normal
weight (18.5e24.9 kg/m2), overweight (25.0e29.9 kg/m2), and
obese (30.0 kg/m2 or higher). GWG was calculated by subtracting
each woman's pregestational weight from her weight at delivery.
Womenwere categorized into three groups based onpregestational
BMI and GWG relative to the 2009 IOM recommendations: (1)
weight gain below the IOM guidelines; (2) weight gain within the
IOM guidelines; and (3) weight gain above the IOM guidelines. The
2009 IOM GWG recommendation is for underweight, normal
weight, overweight, and obese women to gain 12.5e18 kg,
11.5e16 kg, 7e11.5 kg, and 5e9 kg, respectively [20].
To study the prevalence of pregestational underweight, normal
weight, overweight, and obesity and the associations between
maternal pregestational BMI and adverse pregnancy outcomes, we
analyzed all deliveries after 24 0/7 weeks of gestation (n¼ 12,718),
excluding pregnancies complicated by multiple gestations
(n¼ 553) and fetal chromosomal or structural anomalies (n¼ 101).
A total of 12,064 deliveries were selected for these purposes and
deﬁned as Cohort 1.
To evaluate the effect of GWG on the rates of adverse pregnancy
outcomes between women of different pregestational BMIcategories, we analyzed all deliveries after 37 0/7 weeks of gesta-
tion (n¼ 11,268), excluding pregnancies complicated by multiple
gestations (n¼ 169), fetal chromosomal or structural anomalies
(n¼ 78), and fetal demise (n¼ 4). Women with pregestational
diabetes mellitus (n¼ 28) and chronic hypertension (n¼ 16) were
also excluded. Overall, a total of 10,973 deliveries were selected as
Cohort 2 and analyzed for this purpose.
We examined the following maternal and neonatal outcomes:
GDM [21], preeclampsia [22], premature rupture of membranes,
acute chorioamnionitis [23], placenta previa [24], placental
abruption [25], placenta accreta [26], postpartum hemorrhage
(>500 mL for vaginal delivery and >1000 mL for cesarean de-
livery), operative vaginal delivery, severe perineal injury (3rd and
4th degree perineal injury), primary cesarean delivery (deﬁned as a
cesarean delivery performed for the 1st time on a pregnant
woman), indications for primary cesarean delivery including
dysfunctional labor, malpresentation, abnormal fetal heart rate
pattern, and cephalopelvic disproportion, preterm delivery
(<37weeks of gestation), low birth weight (<2500 g), SGA (deﬁned
as birth weight below the 10th percentile of meanweight corrected
for fetal sex and gestational age), LGA (deﬁned as birth weight
above the 90th percentile of mean weight corrected for fetal sex
and gestational age), macrosomia (>4000 g), 1-minute and 5-
minute Apgar scores <7, neonatal intensive care unit (NICU)
admission, fetal death (>24 weeks of gestation), and neonatal
death.
Statistical analyses were performed using SPSS software,
version 20.0 (SPSS Inc., Armonk, NY, USA). The categorical variables
were calculated as the number and rate (%) and were compared
between groups using the c2 test. A p value of <0.05 was consid-
ered statistically signiﬁcant. Multivariable logistic regression
analysis was used to control for potential confounding when
assessing the associations between pregestational BMI and
adverse pregnancy outcomes and evaluating the effect of GWG on
the rates of adverse pregnancy outcomes among women of
different pregestational BMI category. Adjusted odds ratios (aOR)
and 95% conﬁdence intervals (CI) were calculated to describe the
relative risk.
Results
Maternal characteristics of thewomenwith singletons delivered
after 24 weeks of gestation (Cohort 1) are shown in Table 1. Nearly
14% of the women were categorized as underweight. In contrast,
the proportion of overweight and obese womenwas 9.0% and 2.2%,
respectively. Compared with women of a normal weight before
pregnancy, the rates of teenage pregnancy, primiparity, and having
epidural analgesia during labor were higher in underweight
women. By contrast, the rates of a prior history of induced abortion
and fetal death, overt diabetes mellitus, and chronic hypertension
were higher in overweight and obese women. In addition, women
with pregestational overweight were more likely to have genetic
amniocentesis than normal weight women.
The associations between pregestational BMI and adverse
pregnancy outcomes are demonstrated in Table 2. Underweight
women were at increased risk for placental abruption (aOR 1.69,
95% CI 1.18e2.41), SGA (aOR 1.85, 95% CI 1.56e2.19), and delivering
of neonates with a low birth weight (aOR 1.57, 95% CI 1.30e1.89)
compared with the women of normal weight. Both overweight and
obese women were more likely to have GDM (aOR 2.15, 95% CI
1.80e2.56; and aOR 3.77, 95% CI 2.81e5.04, respectively), pre-
eclampsia (aOR 3.74, 95% CI 2.75e5.08; and aOR 7.85, 95% CI
5.13e12.00, respectively), dysfunctional labor (aOR 1.47, 95% CI
1.03e2.11; and aOR 3.14, 95% CI 1.55e6.34, respectively), cepha-
lopelvic disproportion (aOR 2.31, 95% CI 1.47e3.09; and aOR 2.67,
Table 1
Characteristics of women with singleton delivered after 24 weeks of gestation during 2009e2015 (Cohort 1).
Underweight (n¼ 1685) Normal weight (n¼ 9021) Overweight (n¼ 1091) Obese (n¼ 267) p
Age (y)
<20 9 (0.5%)** 10 (0.1%) 1 (0.1%) 1 (0.4%) <0.001
20e34 1094 (64.9%)*** 5037 (55.8%) 553 (50.7%)** 132 (49.4%)* <0.001
>34 419 (24.9%)*** 3315 (36.7%) 469 (43.0%) 112 (41.9%) <0.001
Primiparity 1094 (64.9%)*** 5038 (55.8%) 485 (44.5%) 100 (37.5%)*** <0.001
Prior induced abortion 451 (26.8%)** 2702 (30.0%) 374 (34.3%)*** 106 (39.7%)** <0.001
Prior fetal death 5 (0.3%)* 87 (1.0%) 24 (2.2%)*** 7 (2.6%)* <0.001
Prior preterm birth 6 (0.4%) 48 (0.5%) 11 (1.0%) 3 (1.1%) 0.12
Conception by reproductive technology 24 (1.4%) 181 (2.0%) 19 (1.7%) 4 (1.5%) 0.37
Genetic amniocentesis 460 (27.3%)* 3542 (39.3%) 476 (43.6%)** 111 (41.6%) <0.001
Smoking during pregnancy 5 (0.3%) 18 (0.2%) 3 (0.3%) 0 0.60
Overt diabetes mellitus 1 (0.1%) 17 (0.2%) 10 (0.9%)*** 9 (3.4%)*** <0.001
Chronic hypertension 0 11 (0.1%) 11 (1.0%)*** 9 (3.4%)*** <0.001
GBS colonization 238 (14.1%) 1347 (14.9%) 142 (13.0%) 27 (10.1%)* 0.04
Male fetus 844 (50.1%) 4655 (51.6%) 589 (54.0%) 135 (50.6%) 0.25
Epidural analgesia 909 (53.9%)** 4479 (49.7%) 423 (38.8%)*** 77 (28.8%)*** <0.001
Induction of labor 281 (16.7%)** 1790 (19.8%) 220 (20.2%) 50 (18.7%) 0.02
Augmentation of labor 709 (42.1%) 3640 (40.4%) 343 (31.4%)*** 92 (34.5%) <0.001
Data presented as n (%). *p < 0.05; **p < 0.01; ***p < 0.001, compared with women of normal weight before pregnancy.
GBS ¼ group B Streptococcus.
Table 2
Adverse pregnancy outcomes and pregestational weight category in women with singletons delivered after 24 weeks of gestation during 2009e2015 (Cohort 1).
Outcome Underweight
(n¼ 1685)
Normal weight
(n¼ 9021)
Overweight
(n¼ 1091)
Obese
(n¼ 267)
Underweight vs. normal
weight
Overweight vs. normal
weight
Obese vs. normal
weight
Adjusted OR (95% CI) Adjusted OR (95% CI) Adjusted OR (95% CI)
GDM 109 (6.5%) 813 (9.0%) 205 (18.8%) 79 (29.6%) 0.78c (0.64e0.97) 2.15c (1.80e2.56) 3.77c (2.81e5.04)
Preeclampsia 12 (0.7%) 147 (1.6%) 68 (6.2%) 36 (13.5%) 0.44c (0.24e0.80) 3.74c (2.75e5.08) 7.85c (5.13e12.00)
Premature rupture of
membranes
27 (1.6%) 149 (1.7%) 22 (2.0%) 7 (2.6%) 1.00c (0.66e1.52) 1.19c (0.76e1.89) 1.58c (0.73e3.45)
Chorioamnionitis 9 (0.5%) 79 (0.9%) 11 (1.0%) 1 (0.4%) 0.59c (0.29e1.18) 1.25c (0.65e2.40) 0.52c (0.07e3.79)
Placenta previa 38 (2.3%) 226 (2.5%) 32 (2.9%) 4 (1.5%) 0.96c (0.67e1.38) 1.02c (0.69e1.50) 0.47c (0.17e1.30)
Placental abruption 41 (2.4%) 145 (1.6%) 14 (1.3%) 3 (1.1%) 1.69c (1.18e2.41) 0.75c (0.43e1.31) 0.64c (0.20e2.04)
Placenta accreta 9 (0.5%) 44 (0.5%) 3 (0.3%) 1 (0.4%) 1.18c (0.57e2.43) 0.52c (0.16e1.69) 0.67c (0.91e4.90)
Postpartum hemorrhage 12 (0.7%) 165 (1.8%) 15 (1.4%) 1 (0.4%) 0.41c (0.22e0.73) 0.71c (0.42e1.22) 0.19c (0.03e1.36)
Operative vaginal delivery 68 (4.0%) 352 (3.9%) 24 (2.2%) 5 (1.9%) 0.94d (0.72e1.24) 0.72d (0.47e1.11) 0.79d (0.32e1.96)
Severe perineal injurya 130 (11.5%) 607 (11.1%) 38 (7.4%) 7 (6.2%) 0.93e (0.75e1.16) 0.73e (0.51e1.06) 0.67e (0.29e1.53)
Primary cesarean delivery 407 (24.2%) 2224 (24.7%) 324 (29.7%) 68 (25.5%) 0.86d (0.74e1.00) 1.57d (1.32e1.87) 1.05d (0.73e1.50)
Dysfunctional laborb 126 (3.1%) 821 (36.9%) 130 (40.1%) 32 (47.1%) 0.89d (0.64e1.25) 1.47d (1.03e2.11) 3.14d (1.55e6.34)
Malpresentationb 108 (26.5%) 481 (21.6%) 63 (19.4%) 12 (17.6%) 1.17d (0.89e1.54) 0.83d (0.60e1.16) 0.70d (0.34e1.43)
Abnormal FHR patternb 65 (16.0%) 327 (14.7%) 40 (12.3%) 6 (8.8%) 1.12d (0.83e1.51) 0.80d (0.56e1.15) 0.55d (0.23e1.32)
Cephalopelvic
disproportionb
23 (5.7%) 165 (7.4%) 43 (13.3%) 11 (16.2%) 0.68d (0.43e1.07) 2.31d (1.47e3.09) 2.67d (1.32e5.40)
Preterm delivery 128 (7.6%) 752 (8.3%) 114 (10.4%) 49 (18.4%) 0.95c (0.78e1.16) 1.09c (0.88e1.36) 1.89c (1.34e2.67)
Low birth weight 162 (9.6%) 594 (6.6%) 832 (7.6%) 25 (9.4%) 1.57c (1.30e1.89) 1.03c (0.80e1.32) 1.12c (0.72e1.76)
SGA 207 (12.3%) 614 (6.8%) 72 (6.6%) 11 (4.1%) 1.85c (1.56e2.19) 0.97c (0.75e1.25) 0.54c (0.29e1.02)
LGA 65 (3.9%) 741 (8.2%) 169 (15.5%) 52 (19.5%) 0.50c (0.38e0.64) 1.86c (1.55e2.23) 2.32c (1.67e3.20)
Macrosomia 13 (0.8%) 156 (1.7%) 35 (3.2%) 12 (4.5%) 0.47c (0.27e0.83) 1.81c (1.24e2.64) 2.51c (1.35e4.64)
1-min Apgar score <7 17 (1.0%) 127 (1.4%) 19 (1.7%) 6 (2.2%) 0.70c (0.42e1.17) 1.22c (0.75e2.0) 1.71c (0.74e3.95)
5-min Apgar score <7 4 (0.2%) 31 (0.3%) 10 (0.9%) 0 0.67c (0.23e1.91) 2.46c (1.19e5.09) Not estimable
Fetal death 3 (0.2%) 17 (0.2%) 6 (0.5%) 0 0.84c (0.24e2.92) 2.69c (1.04e6.95) Not estimable
Neonatal death 0 4 (0.0%) 3 (0.3%) 0 Not estimable 6.61c (1.36e32.15) Not estimable
NICU admission 64 (3.8%) 363 (4.0%) 47 (4.3%) 25 (9.4%) 0.92c (0.70e1.21) 0.96c (0.70e1.32) 1.99c (1.26e3.14)
Data presented as number (%). a Among women with a vaginal delivery; b among women with primary cesarean delivery; c adjusted for maternal age at delivery, parity, prior
fetal death, prior preterm birth, conception methods, genetic amniocentesis, smoking during pregnancy, group B streptococcal colonization at the genitorectal tract, and fetal
sex; d adjusted for maternal age at delivery, parity, prior fetal death, prior preterm birth, conception methods, genetic amniocentesis, smoking during pregnancy, group B
streptococcal colonization at the genitorectal tract, fetal sex, and intrapartum epidural analgesia; and e adjusted for maternal age at delivery, parity, prior fetal death, prior
preterm birth, conception methods, genetic amniocentesis, smoking during pregnancy, group B streptococcal colonization at the genitorectal tract, fetal sex, intrapartum
epidural analgesia, and operative vaginal delivery.
CI ¼ conﬁdence interval; FHR ¼ fetal heart rate; GDM ¼ gestational diabetes mellitus; LGA ¼ large-for-gestational age; NICU ¼ neonatal intensive care unit; OR ¼ odds ratio;
SGA ¼ small-for-gestational age.
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and aOR 2.32, 95% CI 1.67e3.20, respectively), and macrosomia
(aOR 1.81, 95% CI 1.24e2.64; and aOR 2.51 95% CI 1.35e4.64,
respectively) thanwomen of normal weight. Furthermore, the risks
for primary cesarean delivery, 5-minute Apgar score <7, fetal and
neonatal death were increased in women with overweight, whilethe risks for preterm delivery and NICU admission were higher in
obese women.
Maternal characteristics of the women with a live singleton
delivered after 37 weeks of gestation with information of GWG
(Cohort 2) are shown in Table 3. Noticeably, underweight women
were more likely to have GWG below the 2009 IOM guidelines
T.-H. Hung, T.-T. Hsieh / Taiwanese Journal of Obstetrics & Gynecology 55 (2016) 575e581578while overweight and obese womenwere more likely to have GWG
above the guidelines compared with the women with pregesta-
tional normal weight.
To investigate whether GWG has a differential effect on the rates
of various adverse pregnancy outcomes among women with
different pregestational BMI categories, the associations between
maternal and neonatal outcomes and GWGwith respect to the 2009
IOM guidelines were studied separately in underweight women
(Table 4), normal weight (Table 5), and overweight/obesity (Table 6).
For underweight women, GWG below the IOM guidelines were
associated with higher rates of GDM (aOR 1.66, 95% CI 1.07e2.56),
lowbirthweight (aOR2.37, 95%CI 1.47e3.82), andSGA (aOR2.17, 95%
CI 1.56e3.02), while GWG above the IOM guidelines were with
higher rates of primary cesarean delivery (aOR 2.32, 95% CI
1.45e3.72), LGA (aOR 2.58, 95% CI 1.38e4.81), andmacrosomia (aOR
5.69, 95% CI 1.46e22.21). For women with a normal weight before
pregnancy, GWG below the IOM guidelines were associated with
higher rates ofGDM(aOR1.49, 95%CI 1.25e1.78), placental abruption
(aOR 1.84, 95% CI 1.16e2.92), low birth weight (aOR 1.68, 95% CI
1.23e2.29), and SGA (aOR 1.55, 95% CI 1.27e1.89), whereas GWG
above the guidelines were with higher rates of preeclampsia (aOR
3.65, 95% CI 2.18e6.10), primary cesarean delivery (aOR 1.35, 95% CI
1.16e1.56), cephalopelvic disproportion (aOR1.88, 95%CI 1.30e2.71),
LGA (aOR 1.80, 95% CI 1.51e2.15), and macrosomia (aOR 2.16, 95% CI
1.53e3.06). As for the overweight and obesewomen,GWGbelow the
guidelines was associated with a higher rate of GDM (aOR 1.75, 95%
CI 1.15e2.68) and GWG above the guidelines was associated with a
higher rate of macrosomia (aOR 2.51, 95% CI 1.14e5.52).
Discussion
In this study, 14% of the women were underweight, 9% were
overweight, and 2.2% were categorized as obese before pregnancy.
The prevalence of underweight, overweight, and obesity in our
population is different from European [1,15], American [2e4], and
Chinese populations [5,6], but similar to a report from Japan [10].
Nevertheless, our study conﬁrmed most prior reports that inap-
propriate pregestational weight is associated with increased risks
for adverse pregnancy outcomes [5,6,8e15]; pregestational un-
derweight women were at risks for placental abruption, SGA, and
low birth weight, whereas overweight and obese women wereTable 3
Characteristics of women with live singleton delivered after 37 weeks of gestation durin
Underweight (n¼ 1556) Normal w
Age (y)
<20 8 (0.5%)** 9 (0.1%)
20e34 1163 (74.7%)*** 5253 (63
>34 385 (24.7%)*** 2985 (63
Weight gain during pregnancy
Below IOM guideline 691 (44.4%)*** 2304 (27
Within IOM guideline 718 (46.4%) 3824 (46
Above IOM guideline 147 (9.4%)*** 2116 (25
Primiparity 1009 (64.8%)*** 4635 (56
Prior induced abortion 419 (26.9%)* 2452 (29
Prior fetal death 5 (0.3%)* 77 (0.9%)
Prior preterm birth 1 (0.1%) 24 (0.3%)
Conception by reproductive technology 18 (1.2%) 150 (1.8%
Genetic amniocentesis 417 (26.8%)*** 3214 (39
Smoking during pregnancy 5 (0.3%) 16 (0.2%)
Placenta previa 28 (1.8%) 166 (2.0%
GBS colonization 233 (15.0%) 1309 (15
Male fetus 771 (49.6%) 4251 (51
Epidural analgesia 871 (56.0%)** 4270 (51
Induction of labor 268 (17.2%)** 1713 (20
Augmentation of labor 667 (42.9%) 3423 (41
Data presented as n (%). *p < 0.05; **p < 0.01; ***p < 0.001, compared with women of n
GBS ¼ group B streptococcus; IOM¼ Institute of Medicine.more likely to have GDM, preeclampsia, primary cesarean delivery,
LGA, and macrosomia than women of normal weight. Compared
with previous studies on Taiwanese women [11,16,17], the strength
of current study lies in its inclusion of both nulliparous and
multiparous women, a large sample size, the adjustment for as
many confounding factors as possible, and the use of patient
interview and medical record data rather than vital statistics or
birth certiﬁcate data; thus, the associations of pregestational BMI
and GWG with respect to the 2009 IOM guidelines with pregnancy
outcomes can be investigated objectively.
Another important ﬁnding of this study is that we found GWG
relative to the IOM guidelines has a differential effect on the rates of
adverse pregnancy outcomes among women of different pregesta-
tional weight categories. For women with pregestational under-
weight or normal weight, GWG below the IOM guidelines increased
the risks of low birth weight and SGA, while GWG above the IOM
guidelines increased the risks of LGA and macrosomia, compared
with the women of similar pregestational weight category but with
GWG within the IOM guidelines. For women with pregestational
overweight or obesity, GWG above the IOM guidelines similarly
increased the risk of macrosomia, but GWG below the IOM guide-
lines was not associated with increased risk of SGA or low birth
weight compared with the women with GWG within the IOM
guidelines. These results indicate that nutritional plan should be
individualized according to pregestational BMI and highlight the
importance of adherence to the IOM recommendations to optimize
fetal growth.
Consistent with our previous study [25], maternal underweight
is associated with 1.7-fold increased risk for placental abruption
than normal weight women. Our recent study also showed that
GWG below the IOM guidelines was an independent risk factor for
placental abruption [18]. In the present study, we further clarify
that the effect of inadequate GWG on the development of placental
abruption mainly occurred in women of normal weight. Although
the exact mechanism remains unclear, these results suggest that
nutrition before and during pregnancy may play a role in the
occurrence of placental abruption.
Similar to our previous report [22], women with pregestational
overweight or obesity carried a 3.7 to 7.9-fold increased risk for
preeclampsia. Furthermore, the risk of preeclampsia increasedwith
GWG above the IOM guidelines in women with normalg 2009e2015 (Cohort 2).
eight (n¼ 8247) Overweight (n¼ 961) Obese (n¼ 209) p
1 (0.1%) 0 0.02
.7%) 546 (56.8%)** 124 (59.3%) <0.001
.7%) 414 (43.1%)*** 85 (40.7%) <0.001
.9%) 126 (13.1%)*** 35 (16.7%)*** <0.001
.4%) 333 (34.7%)*** 70 (33.5%)*** <0.001
.7%) 502 (52.2%)*** 104 (49.8%)*** <0.001
.2%) 429 (44.6%)*** 73 (34.9%)*** <0.001
.7%) 332 (34.5%)** 76 (36.4%)* <0.001
17 (1.8%)* 3 (1.4%) <0.001
4 (0.4%) 0 0.14
) 14 (1.5%) 2 (1.0%) 0.18
.0%) 416 (43.3%)* 83 (39.7%) <0.001
2 (0.2%) 0 0.62
) 24 (2.5%) 3 (1.4%) 0.61
.9%) 138 (14.4%) 26 (12.4%) 0.29
.5%) 512 (53.3%) 99 (47.4%) 0.18
.8%) 402 (41.8%)* 70 (33.5%)* <0.001
.8%) 207 (21.5%) 45 (21.5%) 0.01
.5%) 319 (33.2%)*** 77 (36.8%) <0.001
ormal weight before pregnancy.
Table 4
Adverse pregnancy outcomes associatedwith gestational weight gain according to Institute ofMedicine (IOM) guidelines inwomenwith pregestational underweight in Cohort
2.a
Outcome Below IOM guidelines Within IOM guidelines Above IOM guidelines Below vs. within Above vs. within
(n¼ 691) (n¼ 718) (n¼ 147) Adjusted OR (95% CI) Adjusted OR (95% CI)
Gestational diabetes mellitus 60 (8.7%) 36 (5.0%) 3 (2.0%) 1.66d (1.07e2.56) 0.36d (0.11e1.19)
Preeclampsia 3 (0.4%) 2 (0.3%) 2 (1.4%) 1.72d (0.28e10.48) 4.58d (0.62e34.14)
Premature rupture of membranes 3 (0.4%) 3 (0.4%) 1 (0.7%) 1.28d (0.24e6.85) 1.15d (0.11e12.48)
Chorioamnionitis 2 (0.3%) 3 (0.4%) 3 (2.0%) 0.68d (0.11e4.14) 4.34d (0.83e22.72)
Placental abruption 16 (2.3%) 15 (2.1%) 1 (0.7%) 0.96d (0.46e2.00) 0.32d (0.04e2.53)
Placenta accreta 3 (0.4%) 3 (0.4%) 1 (0.7%) 0.80d (0.15e4.23) 1.95d (0.17e22.10)
Postpartum hemorrhage 5 (0.7%) 7 (1.0%) 0 0.64d (0.20e2.13) Not estimable
Operative vaginal delivery 29 (4.2%) 32 (4.5%) 5 (3.4%) 1.00e (0.59e1.71) 0.72e (0.27e1.94)
Severe perineal injuryb 53 (11.0%) 68 (13.3%) 6 (7.8%) 0.84f (0.57e1.25) 0.34f (0.14e0.83)
Primary cesarean delivery 143 (20.7%) 151 (21.0%) 54 (36.7%) 0.94e (0.68 e1.29) 2.32e (1.45e3.72)
Dysfunctional laborc 33 (23.1%) 55 (36.4%) 30 (55.6%) 0.60e (0.28e1.31) 1.72e (0.63e4.70)
Malpresentationc 45 (31.5%) 35 (23.2%) 6 (11.1%) 1.11e (0.61e2.03) 0.46e (0.16e1.33)
Abnormal FHR patternc 18 (12.6%) 27 (17.9%) 5 (9.3%) 0.65e (0.33e1.30) 0.39e (0.13e1.17)
Cephalopelvic disproportionc 13 (9.1%) 6 (4.0%) 3 (5.6%) 2.19e (0.79e6.07) 1.77e (0.41e7.60)
Low birth weight 59 (8.5%) 27 (3.8%) 2 (1.4%) 2.37d (1.47e3.82) 0.35d (0.08e1.50)
SGA 117 (16.9%) 63 (8.8%) 10 (6.8%) 2.17d (1.56e3.02) 0.73d (0.36e1.47)
LGA 8 (1.2%) 34 (4.7%) 18 (12.2%) 0.22d (0.10e0.49) 2.58d (1.38e4.81)
Macrosomia 3 (0.4%) 4 (0.6%) 5 (3.4%) 0.83d (0.18e3.80) 5.69d (1.46e22.21)
1-min Apgar score <7 4 (0.6%) 5 (0.7%) 0 0.76d (0.19e3.07) Not estimable
NICU admission 9 (1.3%) 11 (1.5%) 1 (0.7%) 0.75d (0.30e1.84) 0.44d (0.06e3.51)
Data presented as n (%). a No cases of 5-minute Apgar score <7 and neonatal death; b among women with a vaginal delivery; c among women with primary cesarean delivery;
d adjusted for maternal age at delivery, parity, prior fetal death, prior preterm birth, conception methods, genetic amniocentesis, smoking during pregnancy, group B
streptococcal colonization at the genitorectal tract, and fetal sex; e adjusted for maternal age at delivery, parity, prior fetal death, prior preterm birth, conception methods,
genetic amniocentesis, smoking during pregnancy, group B streptococcal colonization at the genitorectal tract, fetal sex, and intrapartum epidural analgesia; and f adjusted for
maternal age at delivery, parity, prior fetal death, prior preterm birth, conception methods, genetic amniocentesis, smoking during pregnancy, group B streptococcal colo-
nization at the genitorectal tract, fetal sex, intrapartum epidural analgesia, and operative vaginal delivery.
CI ¼ conﬁdence interval; FHR ¼ fetal heart rate; LGA ¼ large-for-gestational age; OR ¼ odds ratio; NICU ¼ neonatal intensive care unit; SGA ¼ small-for-gestational age.
Table 5
Adverse pregnancy outcomes associated with gestational weight gain according to Institute of Medicine (IOM) guidelines in women with pregestational normal weight in
Cohort 2.
Outcome Below IOM guidelines Within IOM guidelines Above IOM guidelines Below vs. within Above vs. within
(n¼ 2304) (n¼ 3827) (n¼ 2116) Adjusted OR (95% CI) Adjusted OR (95% CI)
GDM 264 (11.5%) 299 (7.8%) 145 (6.9%) 1.49c (1.25e1.78) 0.89c (0.72e1.10)
Preeclampsia 14 (0.6%) 22 (0.6%) 47 (2.2%) 1.13c (0.58e2.22) 3.65c (2.18e6.10)
Premature rupture of membranes 8 (0.3%) 16 (0.4%) 7 (0.3%) 0.81c (0.34e1.91) 0.81c (0.33e2.00)
Chorioamnionitis 14 (0.6%) 35 (0.9%) 16 (0.8%) 0.77c (0.41e1.45) 0.68c (0.37e1.24)
Placental abruption 38 (1.6%) 36 (0.9%) 20 (0.9%) 1.84c (1.16e2.92) 1.02c (0.58e1.77)
Placenta accreta 7 (0.3%) 19 (0.5%) 12 (0.6%) 0.56c (0.23e1.34) 1.22c (0.59e2.52)
Postpartum hemorrhage 42 (1.8%) 74 (1.9%) 39 (1.8%) 0.92c (0.62e1.35) 0.97c (0.65e1.44)
Operative vaginal delivery 97 (4.2%) 162 (4.2%) 80 (3.8%) 1.10d (0.84e1.43) 0.82d (0.62e1.08)
Severe perineal injurya 191 (12.4%) 283 (11.7%) 122 (10.0%) 1.12e (0.91e1.38) 0.76e (0.60e0.97)
Primary cesarean delivery 412 (17.9%) 882 (23.0%) 644 (30.4%) 0.76d (0.65e0.89) 1.35d (1.16e1.56)
Dysfunctional laborb 138 (33.5%) 377 (42.7%) 284 (44.1%) 0.77d (0.54e1.09) 0.96d (0.71e1.29)
Malpresentationb 90 (21.8%) 193 (21.9%) 102 (15.8%) 0.74d (0.54e1.03) 0.66d (0.49e0.90)
Abnormal FHR patternb 63 (15.3%) 112 (12.7%) 88 (13.7%) 1.32d (0.94e1.86) 1.06d (0.78e1.43)
Cephalopelvic disproportionb 24 (5.8%) 60 (6.8%) 76 (11.8%) 0.77d (0.47e1.27) 1.88d (1.30e2.71)
Low birth weight 86 (3.7%) 87 (2.3%) 29 (1.4%) 1.68c (1.23e2.29) 0.58c (0.38e0.90)
SGA 199 (8.6%) 233 (6.1%) 90 (4.3%) 1.55c (1.27e1.89) 0.65c (0.50e0.83)
LGA 103 (4.5%) 306 (8.0%) 274 (12.9%) 0.52c (0.41e0.65) 1.80c (1.51e2.15)
Macrosomia 17 (0.7%) 63 (1.6%) 74 (3.5%) 0.46c (0.27e0.79) 2.16c (1.53e3.06)
1-min Apgar score <7 19 (0.8%) 24 (0.6%) 14 (0.7%) 1.37c (0.75e2.52) 1.05c (0.54e2.04)
5-min Apgar score <7 0 2 (0.1%) 2 (0.1%) Not estimable 1.73c (0.24e12.50)
Neonatal death 0 0 1 (0.0%) Not estimable Not estimable
NICU admission 41 (1.8%) 50 (1.3%) 30 (1.4%) 1.45c (0.95e2.20) 1.03c (0.65e1.63)
Data presented as n (%). a Among women with a vaginal delivery; b among women with primary cesarean delivery; c adjusted for maternal age at delivery, parity, prior fetal
death, prior preterm birth, conception methods, genetic amniocentesis, smoking during pregnancy, group B streptococcal colonization at the genitorectal tract, and fetal sex;
d adjusted for maternal age at delivery, parity, prior fetal death, prior preterm birth, conception methods, genetic amniocentesis, smoking during pregnancy, group B
streptococcal colonization at the genitorectal tract, fetal sex, and intrapartum epidural analgesia; and e adjusted for maternal age at delivery, parity, prior fetal death, prior
preterm birth, conception methods, genetic amniocentesis, smoking during pregnancy, group B streptococcal colonization at the genitorectal tract, fetal sex, intrapartum
epidural analgesia, and operative vaginal delivery.
CI ¼ conﬁdence interval; FHR ¼ fetal heart rate; GDM ¼ gestational diabetes mellitus; LGA ¼ large-for-gestational age; OR ¼ odds ratio; NICU ¼ neonatal intensive care unit;
SGA ¼ small-for-gestational age.
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Table 6
Adverse pregnancy outcomes associated with gestational weight gain according to Institute of Medicine (IOM) guidelines in women with pregestational overweight and
obesity in Cohort 2.a
Outcome Below IOM guidelines Within IOM guidelines Above IOM guidelines Below vs. within Above vs. within
(n¼ 161) (n¼ 403) (n¼ 606) Adjusted OR (95% CI) Adjusted OR (95% CI)
GDM 49 (30.4%) 80 (19.9%) 82 (13.5%) 1.75d (1.15e2.68) 0.61d (0.43e0.87)
Preeclampsia 5 (3.1%) 15 (3.7%) 28 (4.6%) 0.76d (0.27e2.16) 1.24d (0.64e2.41)
Premature rupture of membranes 2 (1.2%) 1 (0.2%) 1 (0.2%) 6.98d (0.53e92.45) 0.43d (0.03e7.16)
Chorioamnionitis 1 (0.6%) 3 (0.7%) 7 (1.2%) 0.66d (0.06e7.16) 1.36d (0.33e5.60)
Placental abruption 2 (1.2%) 6 (1.5%) 5 (0.8%) 1.04d (0.19e5.67) 0.55d (0.16e1.92)
Placenta accreta 1 (0.6%) 1 (0.2%) 2 (0.3%) 2.43d (0.14e42.02) 1.95d (0.17e22.53)
Postpartum hemorrhage 4 (2.5%) 5 (1.2%) 7 (1.2%) 1.91d (0.49e7.40) 1.16d (0.36e3.79)
Operative vaginal delivery 3 (1.9%) 12 (3.0%) 14 (2.3%) 0.70e (0.19e2.62) 0.67e (0.30e1.51)
Severe perineal injuryb 8 (9.3%) 21 (10.2%) 16 (5.6%) 0.96f (0.36e2.51) 0.38f (0.18e0.80)
Primary cesarean delivery 34 (21.1%) 89 (22.1%) 197 (32.5%) 0.95e (0.55e1.64) 1.32e (0.92e1.90)
Dysfunctional laborc 11 (32.4%) 42 (47.2%) 95 (48.2%) 0.76e (0.23e2.52) 1.25e (0.58e2.67)
Malpresentationc 9 (26.5%) 14 (15.7%) 32 (16.2%) 1.20e (0.39e3.72) 1.01e (0.45e2.28)
Abnormal FHR patternc 4 (11.8%) 13 (14.6%) 19 (9.6%) 0.85e (0.24e3.00) 0.65e (0.29e1.45)
Cephalopelvic disproportionc 4 (11.8%) 12 (13.5%) 33 (16.8%) 0.69e (0.19e2.51) 1.26e (0.57e2.78)
Low birth weight 7 (4.3%) 8 (2.0%) 14 (2.3%) 2.25d (0.78e6.44) 1.09d (0.44e2.68)
SGA 12 (7.5%) 23 (5.7%) 24 (4.0%) 1.30d (0.62e2.72) 0.64d (0.35e1.16)
LGA 18 (11.2%) 61 (15.1%) 107 (17.7%) 0.66d (0.37e1.16) 1.30d (0.91e1.86)
Macrosomia 6 (3.7%) 9 (2.2%) 30 (5.0%) 1.72d (0.59e5.03) 2.51d (1.14e5.52)
1-min Apgar score <7 1 (0.6%) 1 (0.2%) 2 (1.0%) 2.59d (0.16e42.64) 4.23d (0.50e35.63)
NICU admission 0 6 (1.5%) 8 (1.3%) Not estimable 0.77d (0.25e2.36)
Data presented as n (%). a No cases of 5-minute Apgar score less than 7 and neonatal death; and b among women with a vaginal delivery. c Among women with primary
cesarean delivery; d adjusted for maternal age at delivery, parity, prior fetal death, prior preterm birth, conceptionmethods, genetic amniocentesis, smoking during pregnancy,
group B streptococcal colonization at the genitorectal tract, and fetal sex; e adjusted for maternal age at delivery, parity, prior fetal death, prior preterm birth, conception
methods, genetic amniocentesis, smoking during pregnancy, group B streptococcal colonization at the genitorectal tract, fetal sex, and intrapartum epidural analgesia; and f
adjusted for maternal age at delivery, parity, prior fetal death, prior preterm birth, conception methods, genetic amniocentesis, smoking during pregnancy, group B strep-
tococcal colonization at the genitorectal tract, fetal sex, intrapartum epidural analgesia, and operative vaginal delivery.
CI ¼ conﬁdence interval; FHR ¼ fetal heart rate; GDM ¼ gestational diabetes mellitus; LGA ¼ large-for-gestational age; OR ¼ odds ratio; NICU ¼ neonatal intensive care unit;
SGA ¼ small-for-gestational age.
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weight, overweight, or obese. Together, these ﬁndings imply that
the obstetric complications of maternal obesity such as pre-
eclampsia are generally related to issues of pregestational obesity
rather than excessiveweight gain during pregnancy that results in a
nonobese women becoming obese.
Our study conﬁrms most prior studies that pregestational
overweight and obesity are independent risk factors for GDM [13].
However, women with GWG below the IOM guidelines were
associated with a higher rate of GDM compared with the women
with GWG within the guidelines in all women of different pre-
gestational BMI categories. Because diagnosis of GDM are usually
established at 24e28 weeks of gestation, it is likely that less total
weight gain at delivery in women with GDM is due to the result of
treatment of GDM, including nutritional therapy, modiﬁcation of
life style, regular monitoring of blood sugar levels, and insulin
treatment [21].
Several limitations of our study merit attention. First, our re-
sults were derived from data from women living in Taipei
metropolitan area, thus limiting the generalizability to women in
rural areas. Second, when assessing the association between
GWG and adverse pregnancy outcomes, this study has a limited
sample size of some important but rare pregnancy complications,
such as birth injury, low Apgar score at 5 minutes, and neonatal
death, in women with pregestational overweight and obesity.
Third, the prepregnancy weight was self-reported, which is
subject to recall error and can lead to underestimation or over-
estimation of GWG.Conﬂicts of interest
The authors have no conﬂicts of interest relevant to this article.Funding statement
This work was partly supported by the Ministry of Science and
Technology, Taiwan (103-2314-B-182A-099-MY2) and Chang Gung
Memorial Hospital (CMRPG1C0072).References
[1] Heslehurst N, Ells LJ, Simpson H, Batterham A, Wilkinson J, Summerbell CD.
Trends in maternal obesity incidence rates, demographic predictors, and
health inequalities in 36,821 women over a 15-year period. BJOG 2007;114:
187e94.
[2] Savitz DA, Dole N, Herring AH, Kaczor D, Murphy J, Siega-Riz AM, et al. Should
spontaneous and medically indicated preterm births be separated for studying
aetiology? Paediatr Perinat Epidemiol 2005;19:97e105.
[3] Roman H, Gofﬁnet F, Hulsey TF, Newman R, Robillard PY, Hulsey TC. Maternal
body mass index at delivery and risk of caesarean due to dystocia in low risk
pregnancies. Acta Obstet Gynecol Scand 2008;87:163e70.
[4] Salihu HM, Lynch O, Alio AP, Liu J. Obesity subtypes and risk of spontaneous
versus medically indicated preterm births in singletons and twins. Am J Epi-
demiol 2008;168:13e20.
[5] Li C, Liu Y, Zhang W. Joint and independent associations of gestational weight
gain and pre-pregnancy body mass index with outcomes of pregnancy in
Chinese women: a retrospective cohort study. PLoS One 2015;10:e0136850.
[6] Li N, Liu E, Guo J, Pan L, Li B, Wang P, et al. Maternal prepregnancy body mass
index and gestational weight gain on pregnancy outcomes. PLoS One 2013;8:
e82310.
[7] Catalano PM. Management of obesity in pregnancy. Obstet Gynecol 2007;109:
419e33.
[8] McDonald SD, Han Z, Mulla S, Beyene J. Knowledge Synthesis Group. Over-
weight and obesity in mothers and risk of preterm birth and low birth weight
infants: systematic review and meta-analyses. BMJ 2010;341:c3428.
[9] Aune D, Saugstad OD, Henriksen T, Tonstad S. Maternal body mass index and
the risk of fetal death, stillbirth, and infant death: a systematic review and
meta-analysis. JAMA 2014;311:1536e46.
[10] Murakami M, Ohmichi M, Takahashi T, Shibata A, Fukao A, Morisaki N, et al.
Prepregnancy body mass index as an important predictor of perinatal out-
comes in Japanese. Arch Gynecol Obstet 2005;271:311e5.
[11] Tsai IH, Chen CP, Sun FJ, Wu CH, Yeh SL. Associations of the pre-pregnancy
body mass index and gestational weight gain with pregnancy outcomes in
Taiwanese women. Asia Pac J Clin Nutr 2012;21:82e7.
T.-H. Hung, T.-T. Hsieh / Taiwanese Journal of Obstetrics & Gynecology 55 (2016) 575e581 581[12] Liu Y, Dai W, Dai X, Li Z. Prepregnancy body mass index and gestational
weight gain with the outcome of pregnancy: a 13-year study of 292,568 cases
in China. Arch Gynecol Obstet 2012;286:905e11.
[13] Torloni MR, Betran AP, Horta BL, Nakamura MU, Atallah AN, Moron AF, et al.
Prepregnancy BMI and the risk of gestational diabetes: a systematic review of
the literature with meta-analysis. Obes Rev 2009;10:194e203.
[14] Han Z, Mulla S, Beyene J, Liao G, McDonald SD. Knowledge Synthesis
Group. Maternal underweight and the risk of preterm birth and low birth
weight: a systematic review and meta-analyses. Int J Epidemiol 2011;40:
65e101.
[15] Haugen M, Brantsæter AL, Winkvist A, Lissner L, Alexander J, Oftedal B, et al.
Associations of pre-pregnancy body mass index and gestational weight gain
with pregnancy outcome and postpartum weight retention: a prospective
observational cohort study. BMC Pregnancy Childbirth 2014;14:201.
[16] Tsai YL, Chen LC, Seow KM, Chong KM. The recommendations of the American
Institute of Medicine (IOM) for normal and underweight women to reduce the
risk of low birth weight. Taiwan J Obstet Gynecol 2015;54:1e7.
[17] Tsai YL, Chong KM, Seow KM. Following the 2009 American Institute of
Medicine recommendations for normal body mass index and overweight
women led to an increased risk of fetal macrosomia among Taiwanese
women. Taiwan J Obstet Gynecol 2013;52:341e6.
[18] Hung TH, Chen SF, Hsu JJ, Hsieh TT. Gestational weight gain and risks for
adverse perinatal outcomes: A retrospective cohort study based on the 2009
Institute of Medicine guidelines. Taiwan J Obstet Gynecol 2015;54:421e5.[19] Hung TH, Chen SF, Lo LM, Hsieh TT. Contemporary second stage labor patterns
in Taiwanese women with normal neonatal outcomes. Taiwan J Obstet
Gynecol 2015;54:416e20.
[20] Institute of Medicine and National Research Council Committee to Reex-
amine IOM Pregnancy Weight Guidelines. Weight gain during pregnancy:
reexamining the guidelines. Washington (DC): National Academies Press;
2009.
[21] Hung TH, Hsieh TT. The effects of implementing the International Association
of Diabetes and Pregnancy Study Groups criteria for diagnosing gestational
diabetes on maternal and neonatal outcomes. PLoS One 2015;10:e0122261.
[22] Lee CJ, Hsieh TT, Chiu TH, Chen KC, Lo LM, Hung TH. Risk factors for pre-
eclampsia in an Asian population. Int J Gynaecol Obstet 2000;70:327e33.
[23] Hung TH, Chen SF, Hsu JJ, Hsieh CC, Hsueh S, Hsieh TT. Tumour necrosis factor-
alpha converting enzyme in human gestational tissues from pregnancies
complicated by chorioamnionitis. Placenta 2006;27:996e1006.
[24] Hung TH, Hsieh CC, Hsu JJ, Lo LM, Chiu TH, Hsieh TT. Risk factors for placenta
previa in an Asian population. Int J Gynecol Obstet 2007;97:26e30.
[25] Hung TH, Hsieh CC, Hsu JJ, Lo LM, Chiu TH, Hsieh TT. Risk factors for placental
abruption in an Asian population. Reprod Sci 2007;14:59e65.
[26] Hung TH, Shau WY, Hsieh CC, Chiu TH, Hsu JJ, Hsieh TT. Risk factors for
placenta accreta. Obstet Gynecol 1999;93:545e50.
